Insider Confidence Signals Ideaya’s 2026 Oncology Outlook – Investors Should Watch
Insider buying shows Ideaya’s leaders are confident in upcoming oncology milestones—explore how this boosts long‑term value despite current price volatility.
4 minutes to read